Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kenichi, Kushibiki"'
Autor:
Hidenori, Tanaka, Junji, Mukai, Kenichi, Kushibiki, Sayuri, Mizushima, Kyoko, Maeda, Yuko, Fujimoto, Ryugo, Sawada, Manabu, Oda, Hiroshi, Okuda, Mayumi, Yamaki, Shin, Hashiguchi, Ichiro, Kawai, Izumi, Kawaguchi, Noriyuki, Masuda, Haruhiko, Matsushita
Publikováno v:
Vaccine. 41:365-371
Administration of three doses of Pfizer-BioNTech BNT162b2 COVID-19 mRNA vaccine was completed in Japan in the spring of 2022. This study aimed to evaluate the antibody responses, and kinetics of three doses of vaccine in healthcare workers (HCWs).We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::086c2a13c24ad65e7c6adff91e464161
https://doi.org/10.1016/j.vaccine.2022.11.049
https://doi.org/10.1016/j.vaccine.2022.11.049
Autor:
Makoto Okuda, Yutaka Nagura, Koji Kishino, Naohito Itami, Kenichi Kushibiki, Hiroko Kuribayashi, Mina Komoto, Kohei Saito, Tatsuya Sugimoto, Junichi Terauchi, Akito Nozaki, Shinji Yoshii, Ayako Endo, Tadatsugu Sato, Eizaburo Sueoka, Masayuki Suzuki, Koki Takahashi, Yoko Hidaka, Motohiro Fujii, Kaoru Yashiro
Publikováno v:
Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi; 2024, Vol. 70 Issue 1, p7-11, 5p
Autor:
Kenichi, Kushibiki
Publikováno v:
Rinsho byori. The Japanese journal of clinical pathology. 65(3)
It may not be common for laboratory tests to be employed immediately after a disaster in front-line healthcare settings. However, this is not because laboratory tests are not needed in post-disaster healthcare settings, but because the implementation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c904478f6928bbfea1e75fb7c0809348
https://pubmed.ncbi.nlm.nih.gov/30802010
https://pubmed.ncbi.nlm.nih.gov/30802010